KalVista Pharmaceuticals - 10 Year Stock Price History | KALV

Historical daily share price chart and data for KalVista Pharmaceuticals since 2015 adjusted for splits and dividends. The latest closing stock price for KalVista Pharmaceuticals as of December 15, 2025 is 16.90.

The all-time high KalVista Pharmaceuticals stock closing price was 126.56 on June 08, 2015.
The KalVista Pharmaceuticals 52-week high stock price is 17.30, which is 2.4% above the current share price.
The KalVista Pharmaceuticals 52-week low stock price is 7.30, which is 56.8% below the current share price.
The average KalVista Pharmaceuticals stock price for the last 52 weeks is 12.12.

KalVista Pharmaceuticals Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2025	12.2664	8.8600	16.9100	7.4000	16.9000	99.53%
2024	11.9691	12.1500	16.0400	8.0900	8.4700	-30.86%
2023	9.0043	6.6300	12.2500	6.3000	12.2500	81.21%
2022	11.1822	13.9100	16.9700	4.2000	6.7600	-48.90%
2021	22.0910	18.0800	42.5700	12.3600	13.2300	-30.33%
2020	13.4555	18.0800	19.4700	5.8000	18.9900	6.63%
2019	18.5277	20.0000	31.1000	10.3100	17.8100	-9.82%
2018	13.2330	10.2100	24.0600	7.7900	19.7500	102.56%
2017	8.1100	6.8000	13.5400	5.8400	9.7500	37.91%
2016	11.0371	46.6200	46.7600	6.1500	7.0700	-86.05%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.855B	$0.000B
KalVista Pharmaceuticals, Inc. is a pharmaceuticals company. It engages in discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product portfolio consist hereditary angioedema and diabetic macular edema, KVD818 and KVD001, which are in clinical stage. KalVista Pharmaceuticals, Inc., formerly known as Carbylan Therapeutics, Inc., is headquartered in Cambridge, United States.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.450B	33.97
Zoetis (ZTS)	United States	$52.293B	18.72
Takeda Pharmaceutical (TAK)	Japan	$45.598B	9.31
Daiichi Sankyo, - (DSNKY)	Japan	$40.539B	20.19
BeOne Medicines - (ONC)	Switzerland	$37.820B	185.50
Sandoz Group AG (SDZNY)	Switzerland	$31.838B	0.00
United Therapeutics (UTHR)	United States	$21.270B	18.72
Merck (MKKGY)	Germany	$17.881B	11.02
Neurocrine Biosciences (NBIX)	United States	$15.235B	36.56
Shionogi (SGIOY)	Japan	$14.445B	13.27
Summit Therapeutics (SMMT)	United States	$13.549B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.091B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$12.978B	0.00
IPSEN (IPSEY)	France	$11.918B	0.00
Orion OYJ (ORINY)	Finland	$9.738B	27.82
Corcept Therapeutics (CORT)	United States	$9.256B	99.99
Eisai (ESAIY)		$8.400B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.305B	35.29
Grifols, S.A (GRFS)	Spain	$6.284B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.238B	18.97
Crinetics Pharmaceuticals (CRNX)	United States	$4.791B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.544B	0.00
NewAmsterdam Pharma (NAMS)	Netherlands	$4.224B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.838B	18.22
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.564B	0.00
Ocular Therapeutix (OCUL)	United States	$3.102B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.903B	9.26
Soleno Therapeutics (SLNO)	United States	$2.793B	0.00
Dyne Therapeutics (DYN)	United States	$2.752B	0.00
Hypermarcas (HYPMY)	Brazil	$2.737B	18.79
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.090B	24.77
Avadel Pharmaceuticals (AVDL)	Ireland	$2.086B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.911B	36.81
Harrow (HROW)	United States	$1.743B	106.96
BioCryst Pharmaceuticals (BCRX)	United States	$1.594B	94.62
Collegium Pharmaceutical (COLL)	United States	$1.537B	7.61
Ardelyx (ARDX)	United States	$1.509B	0.00
Oruka Therapeutics (ORKA)	United States	$1.461B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.439B	0.00
Savara (SVRA)	United States	$1.408B	0.00
Relay Therapeutics (RLAY)	United States	$1.392B	0.00
Cronos Group (CRON)	Canada	$1.250B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.190B	0.00
Xencor (XNCR)	United States	$1.180B	0.00
Nektar Therapeutics (NKTR)	United States	$1.113B	0.00
Evotec AG (EVO)	Germany	$1.069B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.012B	0.00
Enliven Therapeutics (ELVN)	United States	$1.001B	0.00
Theravance Biopharma (TBPH)	United States	$0.921B	38.66
Esperion Therapeutics (ESPR)	United States	$0.920B	0.00
Aquestive Therapeutics (AQST)	United States	$0.758B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.740B	6.61
Lyell Immunopharma (LYEL)	United States	$0.732B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.713B	0.00
ProKidney (PROK)	United States	$0.665B	0.00
Bioventus (BVS)	United States	$0.625B	12.80
4D Molecular Therapeutics (FDMT)	United States	$0.619B	0.00
Organogenesis (ORGO)	United States	$0.612B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.582B	13.77
Altimmune (ALT)	United States	$0.550B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.537B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.469B	0.00
Siga Technologies (SIGA)	United States	$0.463B	6.33
Akebia Therapeutics (AKBA)	United States	$0.441B	0.00
Galectin Therapeutics (GALT)	United States	$0.403B	0.00
Nature's Sunshine Products (NATR)	United States	$0.398B	23.69
USANA Health Sciences (USNA)	United States	$0.373B	10.42
Aclaris Therapeutics (ACRS)	United States	$0.352B	0.00
Avalo Therapeutics (AVTX)	United States	$0.337B	0.00
Larimar Therapeutics (LRMR)	United States	$0.335B	0.00
OmniAb (OABI)	United States	$0.310B	0.00
Fractyl Health (GUTS)	United States	$0.307B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.299B	0.00
Relmada Therapeutics (RLMD)	United States	$0.298B	0.00
Protara Therapeutics (TARA)	United States	$0.294B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.273B	0.00
Pyxis Oncology (PYXS)	United States	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.251B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.247B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.227B	0.00
Profound Medical (PROF)	Canada	$0.221B	0.00
MediWound (MDWD)	Israel	$0.211B	0.00
Surrozen (SRZN)	United States	$0.211B	0.00
Journey Medical (DERM)	United States	$0.208B	0.00
AleAnna (ANNA)	United States	$0.196B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.170B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.164B	0.00
Innate Pharma SA (IPHYF)	France	$0.160B	0.00
Gain Therapeutics (GANX)	United States	$0.159B	0.00
Incannex Healthcare (IXHL)	Australia	$0.146B	0.00
Cassava Sciences (SAVA)	United States	$0.142B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.134B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.119B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.108B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.107B	0.00
Avita Medical (RCEL)	United States	$0.106B	0.00
Vivani Medical (VANI)	United States	$0.098B	0.00
Context Therapeutics (CNTX)	United States	$0.096B	0.00
Plus Therapeutics (PSTV)	United States	$0.094B	0.00
Champions Oncology (CSBR)	United States	$0.093B	33.60
VAXART, INC (VXRT)	United States	$0.089B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.080B	0.00
Korro Bio (KRRO)	United States	$0.078B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.077B	0.00
Rafael Holdings (RFL)	United States	$0.076B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.075B	0.00
Assertio Holdings (ASRT)	United States	$0.073B	0.00
Dominari Holdings (DOMH)	United States	$0.071B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.065B	0.00
Lite Strategy (LITS)	United States	$0.063B	0.00
PolyPid (PYPD)	Israel	$0.062B	0.00
Nutriband (NTRB)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.058B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Talphera (TLPH)	United States	$0.055B	0.00
Wellgistics Health (WGRX)	United States	$0.051B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.050B	0.00
Century Therapeutics (IPSC)	United States	$0.049B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.039B	0.00
ElectroCore (ECOR)	United States	$0.038B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.038B	31.62
Mural Oncology (MURA)	Ireland	$0.035B	0.00
FibroGen (FGEN)	United States	$0.034B	0.00
Klotho Neurosciences (KLTO)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Inotiv (NOTV)	United States	$0.026B	0.00
Vyome Holdings (HIND)	United States	$0.026B	0.00
Scienture Holdings (SCNX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.025B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.023B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.023B	0.00
TherapeuticsMD (TXMD)	United States	$0.020B	0.00
Natural Alternatives (NAII)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Lipocine (LPCN)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.016B	0.00
Mangoceuticals (MGRX)	United States	$0.016B	0.00
Cosmos Health (COSM)	United States	$0.015B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Heatwurx (PCSA)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
VYNE Therapeutics (VYNE)	United States	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Ainos (AIMD)	United States	$0.011B	0.00
BioVie (BIVI)	United States	$0.011B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.011B	0.00
CASI Pharmaceuticals (CASI)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.010B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Aptorum Group (APM)	United Kingdom	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
ProPhase Labs (PRPH)	United States	$0.005B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
CDT Equity (CDT)	United States	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.002B	0.00
Aditxt (ADTX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Indivior (INDV)	United States	$0.000B	18.14
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Minerva Neurosciences (NERV)	United States	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00